
AUSTIN, Texas — The Texas state health department has run out of a key treatment to fight the omicron COVID-19 variant, which now makes up 90% of the virus cases in the state.
On Monday, the Texas Department of State Health Services announced that its regional infusion centers in Austin, El Paso, Fort Worth, San Antonio and The Woodlands have run out of the monoclonal antibody sotrovimab.
That antibody has been shown to be effective against the omicron variant. Other monoclonal antibodies have not been shown to be effective against omicron.
The state does not expect to receive another shipment of sotrovimab from the federal government until January.
A shocking new graph of VAERS information reveals the true scale of death being brought on by the covid vaccine.
People who had an appointment scheduled at regional infusion centers for this treatment will be alerted. People who have been diagnosed with a non-omicron variant can receive other monoclonal antibody treatments at the regional infusion centers.